Evolus (NASDAQ: EOLS) reported Q2 EPS of ($0.27), $0.17 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $69.4 million versus the consensus estimate of $82.18 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.